Could a simpler biopsy replace major surgery for inflammatory breast cancer?
NCT ID NCT07080944
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a less invasive procedure called sentinel lymph node biopsy can be safely used after chemotherapy in people with inflammatory breast cancer. Traditionally, these patients need more extensive surgery because the cancer is advanced. The study will check how often the sentinel node can be found and track long-term outcomes like cancer return. About 75 women whose cancer responded well to chemotherapy will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
European Institute of Oncology
RECRUITINGMilan, 20141, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Could a common cholesterol drug boost breast cancer treatment?
- Gene test could guide breast cancer treatment to boost survival
- Can a simple paper tool help melanoma patients make tough biopsy decisions?
- One-Week radiation for breast cancer: MRI precision may cut side effects
- Could a single day of radiation replace weeks of treatment for breast cancer?